Solventum Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$7.0M
Doctors Paid
16,960
Transactions
24,510
2024 Total
$7.0M
Payment Breakdown by Category
Research$1.1M (15.4%)
Consulting$824,859 (11.7%)
Food & Beverage$790,793 (11.2%)
Travel$474,681 (6.7%)
Royalty/License$154,100 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $1.8M | 34 | 25.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.6M | 287 | 22.3% |
| Unspecified | $1.1M | 77 | 15.4% |
| Consulting Fee | $824,859 | 428 | 11.7% |
| Food and Beverage | $790,793 | 22,381 | 11.2% |
| Travel and Lodging | $474,681 | 1,223 | 6.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $170,150 | 30 | 2.4% |
| Royalty or License | $154,100 | 4 | 2.2% |
| Long term medical supply or device loan | $116,782 | 4 | 1.7% |
| Space rental or facility fees (teaching hospital only) | $73,335 | 2 | 1.0% |
| Debt forgiveness | $3,847 | 18 | 0.1% |
| Education | $3,069 | 7 | 0.0% |
| Entertainment | $702.79 | 14 | 0.0% |
| Gift | $87.79 | 1 | 0.0% |
Payments by Type
General
$6.0M
24,433 transactions
Research
$1.1M
77 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | $217,810 | 0 | 17 |
| Breast Reconstruction Registry | $96,533 | 0 | 1 |
| Breast Reconstruction Registry Project | $96,050 | 0 | 2 |
| A randomized, controlled, two-arm clinical study to evaluate clinical efficiency of 3M Digital Bonding versus Direct Bonding | $95,862 | 3 | 26 |
| Wound Registry for Patients Undergoing Surgical Wound Debridements of the Upper or Lower Extremities | $86,084 | 0 | 1 |
| Delayed Primary Closure of Open Abdomen in Dirty Wounds with Negative Pressure Therapies | $56,440 | 0 | 2 |
| Assessing the Applicability of Closed Incision Negative Pressure Wound Threapy to Reduction Mammaplasty | $50,106 | 0 | 1 |
| Prospective, randomized split-mouth design clinical study evaluating the performance of a new dental adhesive, 3M Scotchbond Universal Plus Adhesive compared to 3M Scotchbond Universal Adhesive, when used with 3M Filtek Universal Restorative to restore Class V noncarious cervical lesions | $45,359 | 0 | 2 |
| Exploratory prospective two-arm cohort study to evaluate functional outcomes in patients with high-risk lower extremity fractures requiring open reduction and internal fixation. | $45,354 | 0 | 1 |
| Prospective, randomized, split-mouth study evaluating the clinical performance of a new dental adhesive, 3M Scotchbond Universal Plus Adhesive, compared to 3M Scotchbond Universal Adhesive when used for posterior Class I and Class II restorations with 3M Filtek Universal Restorative | $37,580 | 0 | 1 |
| Use of V.A.C. VERAFLO to Deliver Pro-Healing and Anti-Infective Agents in an Acute Porcine Model of Surgical Wounds | $25,000 | 0 | 1 |
| Application of Prevena Incision Management System in Complex Abdominal Wall Resconstruction with Biological mesh and major laprotomies. | $25,000 | 0 | 1 |
| Evaluation of a Closed Incision Negative Pressure Device (PREVENA) To Prevent Lower Extremity Amputation Wound Complications | $23,940 | 0 | 1 |
| A post-market, prospective, multi-center, single-arm study evaluating the safety and efficacy of the 3M V.A.C. Peel and Place Dressing used in conjunction with 3M V.A.C.Therapy | $22,330 | 0 | 1 |
| Comparison of Negative Pressure Wound Therapy vs Conventional Dressings for the Prevention of Wound Complications following Revision Total Hip Arthroplasty: A Prospective, Randomized, Controlled Trial | $21,875 | 0 | 1 |
| 3M Transcutaneous Oxygen Sensing Monitor for DIEP Flap Patients (TCOM) | $20,000 | 0 | 1 |
| Incisional negative pressure wound therapy for preoperatively irradiated lower extremity soft tissue sarcoma wounds. A prospoective, randomized pilot trial. | $18,000 | 0 | 1 |
| A Prospective, Single-arm,Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | $18,000 | 0 | 2 |
| KERALITCPMCF008: A Prospective, Observational, Post Market Clinical Follow-up (PMCF) Study in Patient using the KerraLite Cool Dressing on Radiation Therapy Damage Wounds, Burns and Dry Wounds | $14,761 | 0 | 3 |
| A Prospective, Observational, Post- Market Clinical Follow-Up (PMCF) Study Observing the Safety and Performance of the SNA Therapy System in Indicated Wound Types | $11,798 | 0 | 1 |
| Shear bond strength of a new RMGI Liner/Base material to sound and caries affected/demineralized dentin | $11,138 | 0 | 1 |
| A post-market, randomized, controlled, multicenter, embedded pilot study evaluating incision and surrounding soft tissue management and functional outcomes using 3M Prevena Restor Therapy System versus standard surgical dressings in revision total knee arthroplasty (The ADVANCE study) | $10,500 | 0 | 1 |
| The effect of light-cured fluoride varnish to remineralize post orthodontic white spot lesions and change the oral microbiome: a double-blind, split-mouth randomized clinical trial | $8,910 | 0 | 1 |
| A Randomized Controlled Clinical Study Evaluating the Efficacy of Solventum Vitrebond Pulp Protect Liner/Base used as a Liner/Base under Dental Restorations | $7,110 | 0 | 1 |
| A Multi-site, Single-Arm Clinical Study Evaluating the Efficacy of Solventum Vitrebond Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure due to Trauma, Deep Caries, or Mechanical Etiology under Dental Restorations | $7,110 | 0 | 1 |
| Impact of Promogran Prisma on pain of split-thickness skin graft donor sites compared to standard of care alone. | $5,979 | 0 | 1 |
| A Prospective, Observational, Post- Market Clinical Follow-Up (PMCF) Study Observing the Safety and Performance of the SNAP Therapy System in Indicated Wound Types | $4,800 | 0 | 2 |
| Orthopontic Bracket Placement Consistency Comparison of Indirect Bonding Methods | $3,750 | 0 | 1 |
| Effect of translucent matrix materials on the physical properties of dental composites | $1,856 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Frank Buttacavoli, Md, MD | Orthopaedic Surgery | San Antonio, TX | $38,928 | $0 |
| Alisha Oropallo, M.d, M.D | Vascular Surgery | Mineola, NY | $38,860 | $0 |
| Dr. Garrett Wirth, M.d, M.D | Plastic Surgery | Newport Beach, CA | $37,473 | $0 |
| Dr. Courtney Dunn, D.d.s., M.s, D.D.S., M.S | Orthodontics and Dentofacial Orthopedics | Litchfield Park, AZ | $36,400 | $0 |
| Luis Fernandez, Md, MD | Trauma Surgery | Tyler, TX | $35,873 | $0 |
| Dr. Mark Causey, Mark Causey, MARK CAUSEY | Orthodontics and Dentofacial Orthopedics | Cumming, GA | $35,763 | $0 |
| Ms. Catherine Milne, Aprn, APRN | Nurse Practitioner | Plymouth, CT | $33,659 | $0 |
| Dr. Javad Parvizi, M.d, M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $32,551 | $0 |
| Dr. Douglas Palaganas, Dds, DDS | Orthodontics and Dentofacial Orthopedics | Wantagh, NY | $31,988 | $0 |
| Kersten Reider, Crnp, CRNP | Primary Care | Mount Penn, PA | $31,938 | $0 |
| Dr. Matthew Dunn, Dds, Ms, DDS, MS | Orthodontics and Dentofacial Orthopedics | Litchfield Park, AZ | $31,599 | $0 |
| Lisa Alvetro Rossman, Dds Msd, DDS MSD | Orthodontics and Dentofacial Orthopedics | Sidney, OH | $28,188 | $0 |
| John Fischer, Md, MD | Plastic Surgery | Philadelphia, PA | $27,647 | $0 |
| Marcos Vargas, Dds Ms, DDS MS | General Practice | Iowa City, IA | $26,189 | $0 |
| Dr. Lisa Davison, Dds, DDS | Orthodontics and Dentofacial Orthopedics | Powell, OH | $25,192 | $0 |
| Dr. Animesh Agarwal, Md, MD | Orthopaedic Surgery | San Antonio, TX | $25,105 | $0 |
| Kara Couch, Np, NP | Family | Washington, DC | $24,778 | $0 |
| Dr. Matthew Larson, Dds, Ms, DDS, MS | Orthodontics and Dentofacial Orthopedics | Altoona, WI | $22,970 | $0 |
| Dr. Philip Wrotslavsky, Dpm, Ceo, DPM, CEO | Foot & Ankle Surgery | Poway, CA | $22,968 | $0 |
| Dr. Carlos Higuera Rueda, M.d, M.D | Adult Reconstructive Orthopaedic Surgery | Weston, FL | $21,796 | $0 |
| Dr. Herbert Cooper, Md, MD | Orthopaedic Surgery | New York, NY | $21,418 | $0 |
| Adam Katz, Md, MD | Plastic and Reconstructive Surgery | Gainesville, FL | $19,292 | $0 |
| Dr. Christopher Pelt, M.d, M.D | Orthopaedic Surgery | Salt Lake City, UT | $18,734 | $0 |
| Dr. Mark Nadeau, D.m.d, D.M.D | Orthodontics and Dentofacial Orthopedics | Kennebunk, ME | $17,842 | $0 |
| Richard Broadbent, D.m.d, M.s, D.M.D, M.S | Orthodontics and Dentofacial Orthopedics | North Ogden, UT | $17,290 | $0 |
Ad
Top Products
- Clarity Aligners $2.2M
- PREVENA $1.2M
Associated Products (14)
- V.A.C.ULTA $239,683
- 3M $129,757
- 3M Skin and Nasal Antiseptic $84,429
- APC Flash-Free Victory Series Low Profile $83,532
- PREVENA RESTOR ARTHROFORM $81,671
- 3M Ioban $52,321
- 3M DuraPrep Surgical $40,228
- Ioban 2 $28,484
- Vanish XT $16,849
- APC II Unitek Gemini $14,258
- 3M SoluPrep $12,439
- V.A.C. GRANUFOAM $12,009
- PROMOGRAN $11,542
- 3M Scotchbond $10,062
Payment Categories
- Food & Beverage $790,793
- Consulting $824,859
- Travel & Lodging $474,681
- Research $1.1M
- Royalties $154,100
About Solventum Corporation
Solventum Corporation has made $7.0M in payments to 16,960 healthcare providers, recorded across 24,510 transactions in the CMS Open Payments database. In 2024, the company paid $7.0M. The top product by payment volume is Clarity Aligners ($2.2M).
Payments were distributed across 166 medical specialties. The top specialty by payment amount is Orthodontics and Dentofacial Orthopedics ($953,933 to 1,412 doctors).
Payment categories include: Food & Beverage ($790,793), Consulting ($824,859), Research ($1.1M), Travel & Lodging ($474,681), Royalties ($154,100).
Solventum Corporation is associated with 14 products in the CMS Open Payments database, including V.A.C.ULTA, 3M, and 3M Skin and Nasal Antiseptic.